Heatstroke: a multicenter study in Southwestern China.

clinical characteristics descriptive study epidemiological patterns heatstroke intensive care units multicenter patient outcomes retrospective

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 05 12 2023
accepted: 08 04 2024
medline: 3 5 2024
pubmed: 3 5 2024
entrez: 3 5 2024
Statut: epublish

Résumé

An increase in Heatstroke cases occurred in southwest China in 2022 due to factors like global warming, abnormal temperature rise, insufficient power supply, and other contributing factors. This resulted in a notable rise in Heatstroke patients experiencing varying degrees of organ dysfunction. This descriptive study aims to analyze the epidemiology and clinical outcomes of Heatstroke patients in the ICU, providing support for standardized diagnosis and treatment, ultimately enhancing the prognosis of Heatstroke. A retrospective, multicenter, descriptive analysis was conducted on Heatstroke patients admitted to ICUs across 83 hospitals in southwest China. Electronic medical records were utilized for data collection, encompassing various aspects such as epidemiological factors, onset symptoms, complications, laboratory data, concurrent infections, treatments, and patient outcomes. The dataset primarily comprised classic heatstroke, with 477 males (55% of total). The patient population had a median age of 72 years (range: 63-80 years). The most common initial symptoms were fever, mental or behavioral abnormalities, and fainting. ICU treatment involved respiratory support, antibiotics, sedatives, and other interventions. Among the 700 ICU admissions, 213 patients had no infection, while 487 were diagnosed with infection, predominantly lower respiratory tract infection. Patients presenting with neurological symptoms initially ( In 2022, the majority of Heatstroke patients in southwest China experienced classical Heatstroke, with many acquiring infections upon admission to the ICU. Moreover, Heatstroke can result in diverse complications.

Sections du résumé

Background UNASSIGNED
An increase in Heatstroke cases occurred in southwest China in 2022 due to factors like global warming, abnormal temperature rise, insufficient power supply, and other contributing factors. This resulted in a notable rise in Heatstroke patients experiencing varying degrees of organ dysfunction. This descriptive study aims to analyze the epidemiology and clinical outcomes of Heatstroke patients in the ICU, providing support for standardized diagnosis and treatment, ultimately enhancing the prognosis of Heatstroke.
Methods UNASSIGNED
A retrospective, multicenter, descriptive analysis was conducted on Heatstroke patients admitted to ICUs across 83 hospitals in southwest China. Electronic medical records were utilized for data collection, encompassing various aspects such as epidemiological factors, onset symptoms, complications, laboratory data, concurrent infections, treatments, and patient outcomes.
Results UNASSIGNED
The dataset primarily comprised classic heatstroke, with 477 males (55% of total). The patient population had a median age of 72 years (range: 63-80 years). The most common initial symptoms were fever, mental or behavioral abnormalities, and fainting. ICU treatment involved respiratory support, antibiotics, sedatives, and other interventions. Among the 700 ICU admissions, 213 patients had no infection, while 487 were diagnosed with infection, predominantly lower respiratory tract infection. Patients presenting with neurological symptoms initially (
Conclusion UNASSIGNED
In 2022, the majority of Heatstroke patients in southwest China experienced classical Heatstroke, with many acquiring infections upon admission to the ICU. Moreover, Heatstroke can result in diverse complications.

Identifiants

pubmed: 38699425
doi: 10.3389/fpubh.2024.1349753
pmc: PMC11064700
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1349753

Informations de copyright

Copyright © 2024 Shi, Wang, Wu, Yang, Wang, Wan, Wang, Feng, Zhang, Li, Wang, Chen, Ai, Zheng, Zhang, He and Heat Stroke Research Group in Southwestern China.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Lvyuan Shi (L)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Bo Wang (B)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Qin Wu (Q)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Jing Yang (J)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Lietao Wang (L)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Dingyuan Wan (D)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Yucong Wang (Y)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Zhongxue Feng (Z)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Department of State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.

Wei Zhang (W)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Department of State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.

Li Li (L)

Department of Critical Care Medicine, The Second People's Hospital of Neijiang City, Neijiang, Sichuan, China.

Wenhu Wang (W)

Department of Critical Care Medicine, Zizhong County People's Hospital, Neijiang, Sichuan, China.

Jun Chen (J)

Department of Critical Care Medicine, The People's Hospital of Jianyang City, Jianyang, Sichuan, China.

Xiaohua Ai (X)

Department of Critical Care Medicine, The People's Hospital of Zhongjiang, Deyang, Sichuan, China.

Jianwei Zheng (J)

Department of Critical Care Medicine, Hejiang People's Hospital, Luzhou, Sichuan, China.

Zhongwei Zhang (Z)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Min He (M)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH